Xeris Pharmaceuticals (2B30) Q4 2024 Earnings Report
DE:2B30 Q4 2024 EPS Results
- Actual EPS
- -EUR 0.03
- Consensus EPS
- -EUR 0.05
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.09
DE:2B30 Q4 2024 Revenue Results
- Actual Revenue
- EUR 53.63M
- Expected Revenue
- EUR 51.85M
- Beat/Miss
- Beat by +EUR 1.78M
- YoY Revenue Growth
- +35.39%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 03/06/2025
- Time
- Before Open
- Conference Call
- Thursday, March 6, 2025
DE:2B30 Upcoming Earnings
Xeris Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:2B30 Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2B30 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.03- | 0 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | 0.01-0.16 | -0.01 | -1700.00% (-0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.000.01 | -0.05 | 116.67% (+0.06) | |
| Mar 02, 2026 | 2025 (Q4) | 0.020.05 | -0.03 | 300.00% (+0.08) | |
| Nov 06, 2025 | 2025 (Q3) | 0.010.00 | -0.1 | 100.00% (+0.10) | |
| Aug 07, 2025 | 2025 (Q2) | -0.02-0.01 | -0.09 | 90.00% (+0.08) | |
| May 08, 2025 | 2025 (Q1) | -0.04-0.05 | -0.12 | 57.14% (+0.07) | |
| Mar 06, 2025 | 2024 (Q4) | -0.05-0.03 | -0.09 | 70.00% (+0.06) | |
| Nov 08, 2024 | 2024 (Q3) | -0.08-0.10 | -0.08 | -22.22% (-0.02) | |
| Aug 08, 2024 | 2024 (Q2) | -0.09-0.09 | -0.12 | 28.57% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed